Squarepoint
VYGR icon

Squarepoint’s Voyager Therapeutics VYGR Stock Holding History

Squarepoint’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-20,877
Closed -$73.1K – 5094
2026
Q2 		$73.1K Buy
+20,877
New +$79.2K ﹤0.01% 4240
2025
Q1 		– Sell
-38,650
Closed -$219K – 5499
2024
Q4 		$219K Sell
38,650
-32,074
-45% -$207K ﹤0.01% 4402
2024
Q3 		$414K Buy
+70,724
New +$514K ﹤0.01% 3242
2023
Q4 		– Sell
-31,181
Closed -$242K – 4560
2023
Q3 		$242K Buy
31,181
+20,506
+192% +$187K ﹤0.01% 3298
2023
Q2 		$122K Sell
10,675
-32,526
-75% -$336K ﹤0.01% 3326
2023
Q1 		$333K Buy
+43,201
New +$344K ﹤0.01% 2514
2022
Q2 		– Sell
-20,066
Closed -$153K – 3427
2022
Q1 		$153K Buy
20,066
+5,248
+35% +$23.4K ﹤0.01% 2542
2021
Q4 		$40K Sell
14,818
-18,439
-55% -$62.9K ﹤0.01% 3052
2021
Q3 		$87K Sell
33,257
-54,703
-62% -$178K ﹤0.01% 2698
2021
Q2 		$363K Buy
87,960
+73,731
+518% +$334K ﹤0.01% 2382
2021
Q1 		$67K Buy
+14,229
New +$97K ﹤0.01% 2967
2020
Q1 		– Sell
-127,179
Closed -$1.77M – 2570
2019
Q4 		$1.77M Sell
127,179
-19,591
-13% -$285K 0.01% 981
2019
Q3 		$2.53M Buy
+146,770
New +$3.08M 0.02% 755
2019
Q1 		– Sell
-34,983
Closed -$329K – 2462
2018
Q4 		$329K Buy
34,983
+19,883
+132% +$255K ﹤0.01% 1460
2018
Q3 		$286K Sell
15,100
-3,700
-20% -$71K ﹤0.01% 1564
2018
Q2 		$367K Buy
+18,800
New +$372K ﹤0.01% 1302
2018
Q1 		– Sell
-13,768
Closed -$229K – 2186
2017
Q4 		$229K Buy
+13,768
New +$236K ﹤0.01% 1720

Other funds holding VYGR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Patriot Financial Group Insurance Agency
Patriot Financial Group Insurance Agency Westborough, Massachusetts $1.05B AUM 21.28% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Squarepoint's VYGR Position: Q3 2026 in Review

Squarepoint sold out of Voyager Therapeutics (VYGR) in Q3 2026, closing a stake of 20,877 shares — an estimated $73.1K sold.

Squarepoint first reported a position in VYGR in Q4 2017 and held it in 17 quarters. The position peaked at $2.53M in Q3 2019. 37 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.

  • Squarepoint reported no remaining Voyager Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Squarepoint sold 20,877 Voyager Therapeutics shares in Q3 2026, an estimated $73.1K.
  • Squarepoint first reported a position in Voyager Therapeutics in Q4 2017 and held it in 17 quarters.
  • Squarepoint's Voyager Therapeutics position peaked at $2.53M in Q3 2019.
  • 37 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.